Pharmacoprint -- a combination of pharmacophore fingerprint and
  artificial intelligence as a tool for computer-aided drug design
  Structural fingerprints and pharmacophore modeling are methodologies that
have been used for at least two decades in various fields of cheminformatics:
from similarity searching to machine learning (ML). Advances in silico
techniques consequently led to combining both these methodologies into a new
approach known as pharmacophore fingerprint. Herein, we propose a
high-resolution, pharmacophore fingerprint called Pharmacoprint that encodes
the presence, types, and relationships between pharmacophore features of a
molecule. Pharmacoprint was evaluated in classification experiments by using ML
algorithms (logistic regression, support vector machines, linear support vector
machines, and neural networks) and outperformed other popular molecular
fingerprints (i.e., Estate, MACCS, PubChem, Substructure, Klekotha-Roth, CDK,
Extended, and GraphOnly) and ChemAxon Pharmacophoric Features fingerprint.
Pharmacoprint consisted of 39973 bits; several methods were applied for
dimensionality reduction, and the best algorithm not only reduced the length of
bit string but also improved the efficiency of ML tests. Further optimization
allowed us to define the best parameter settings for using Pharmacoprint in
discrimination tests and for maximizing statistical parameters. Finally,
Pharmacoprint generated for 3D structures with defined hydrogens as input data
was applied to neural networks with a supervised autoencoder for selecting the
most important bits and allowed to maximize Matthews Correlation Coefficient up
to 0.962. The results show the potential of Pharmacoprint as a new, perspective
tool for computer-aided drug design.
